|
National Stock Number(NSN): 6505-01-095-8570 (6505010958570, 010958570)
| NIIN: |
01-095-8570 |
Item Name: |
OXYCODONE AND ASPIRIN TABLETS |
INC: |
49766
|
| FSC: |
6505
|
Assignment Date: |
Jun-07-1980 |
CRIT: |
X |
IIG: |
49766 |
| ISC: |
5 |
Date Standardized: |
Jun-07-1980 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2024 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.49.0040 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00060-0135-85 |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
3 |
2 |
6 |
54 |
1 |
D |
|
|
|
|
|
NDC00555-0293-04 |
56490
|
BARR LABORATORIES, INC. |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
PERCODAN |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
5 |
1 |
6 |
54 |
4 |
D |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| VA |
JVS |
I |
|
M |
R |
G |
V |
$0.00 |
BT |
|
------- |
May-01-1987 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| VA |
K |
U/I CONTAINS 500 TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT AND 4.500 MILLIGRAMS OXYCODONE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.380 MILLIGRAMS OXYCODONE TEREPHTHALATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|